Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H18N2O2S |
Molecular Weight | 242.338 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
InChI
InChIKey=IUJDSEJGGMCXSG-UHFFFAOYSA-N
InChI=1S/C11H18N2O2S/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)
Molecular Formula | C11H18N2O2S |
Molecular Weight | 242.338 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Sodium thiopental (also known as Sodium Pentothal, thiopental) was discovered in 1930s by investigators working for Abbott Laboratories. Thiopental sodium was used for the induction of general anesthesia and is used as an adjunct to provide hypnosis during balanced anesthesia with other anesthetic agents, including analgesics and muscle relaxants. Thiopental sodium was also used as an adjunct for control of convulsive disorders of various etiology, including those caused by local anesthetics. Finally, thiopental sodium had been used to reduce the intracranial pressure in patients with increased intracranial pressure, if controlled ventilation is provided. Nevertheless, these prescriptions of drug were discontinued. In addition, this drug was banned for use in US executions. Thiopental sodium acts through the CNS with particular activity in the mesencephalic reticular activating system. It was shown, that mechanism of action of sodium thiopental via GABAA receptor. Thiopental binds at a distinct binding site associated with a Cl- ionopore at the GABAA receptor, increasing the duration of time for which the Cl- ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2093872 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18619475 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | PENTOTHAL Approved UsePentothal (Thiopental Sodium for Injection) is indicated (1) as the sole anesthetic agent for brief (15 minute) procedures, (2) for induction of anesthesia prior to administration of other anesthetic agents, (3) to supplement regional anesthesia, (4) to provide hypnosis during balanced anesthesia with other agents for analgesia or muscle relaxation, (5) for the control of convulsive states during or following inhalation anesthesia, local anesthesia, or other causes, (6) in neurosurgical patients with increased intracranial pressure, if adequate ventilation is provided, and (7) for narcoanalysis and narcosynthesis in psychiatric disorders. |
Doses
Dose | Population | Adverse events |
---|---|---|
500 mg multiple, intravenous Dose: 500 mg Route: intravenous Route: multiple Dose: 500 mg Sources: |
unhealthy, 31 years (range: 19 -44 years) Health Status: unhealthy Age Group: 31 years (range: 19 -44 years) Sex: M+F Sources: |
Other AEs: Hypothermia... |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Hypothermia | 1 patient | 500 mg multiple, intravenous Dose: 500 mg Route: intravenous Route: multiple Dose: 500 mg Sources: |
unhealthy, 31 years (range: 19 -44 years) Health Status: unhealthy Age Group: 31 years (range: 19 -44 years) Sex: M+F Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Metabolism of thiopental-S35 and thiopental-2-C14 by a rat liver mince and identification of pentobarbital as a major metabolite. | 1955 Jul |
|
Local anesthetic-induced convulsions in man--an electroencephalographic study. | 1966 Sep-Oct |
|
Thiopentone anaphylaxis--case report. | 1975 Aug |
|
Influence of tetrahydro-aminacrine on muscle pains after suxamethonium. | 1975 Jan 18 |
|
Postischemic brain oxygenation with barbiturate therapy in rats. | 1979 Aug |
|
Cimetidine: does neurotoxicity occur? Report of three cases. | 1979 Mar |
|
Brain blood flow and metabolism after global ischemia and post-insult thiopental therapy in monkeys. | 1979 Sep-Oct |
|
Venous complications after intravenous injection of diazepam, flunitrazepam, thiopentone and etomidate. | 1980 Jun |
|
The safety of etomidate: a new intravenous anaesthetic induction agent. | 1983 Jun |
|
Another case of grand mal seizure after fentanyl administration. | 1984 Apr |
|
Domperidone--an acute dystonic reaction. | 1985 Feb |
|
Thiopental-related immune hemolytic anemia and renal failure. Specific involvement of red-cell antigen I. | 1985 Feb 7 |
|
[Phlebitis of the arm caused by pentothal infusion]. | 1985 Oct-Dec |
|
Etomidate versus thiopental for induction of anesthesia. | 1985 Sep |
|
[Mitral valve prolapse: a factor exacerbating peranesthetic anaphylactic shock]. | 1986 |
|
Asystole associated with vecuronium. | 1986 Aug |
|
Hypertension in bulls and steers anesthetized with guaifenesin-thiobarbiturate-halothane combination. | 1986 Jul |
|
Factors that influence cutaneous reactions following administration of thiopentone and atracurium. | 1988 Oct |
|
Acute macular neuroretinopathy following intravenous sympathomimetics. | 1989 |
|
[Muscular rigidity caused by alfentanil: prevention]. | 1989 Jun |
|
[Hemodynamic effects of the induction of general anesthesia after low thoracic epidural anesthesia]. | 1991 |
|
Effect of some psychotropic drugs and a barbiturate on mycoplasmas. | 2000 Apr |
|
The influence of the timing of administration of thiopentone sodium on nitric oxide-mediated neurotoxicity in vitro. | 2000 Mar 1 |
|
Intravenous midazolam significantly enhances the lethal effect of thiopental but not that of ketamine in mice. | 2001 Dec |
|
Effect of propofol at two injection rates or thiopentone on post-intubation apnoea in the dog. | 2001 Feb |
|
The use of thiopentone/propofol admixture for laryngeal mask airway insertion. | 2001 Feb |
|
Dual effects of melatonin on barbiturate-induced narcosis in rats. | 2001 Mar 16 |
|
Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients. | 2001 Nov |
|
Effect of thiopental, propofol, and etomidate on vincristine toxicity in PC12 cells. | 2002 |
|
Interaction of intravenous anesthetics with recombinant human M1-M3 muscarinic receptors expressed in chinese hamster ovary cells. | 2002 Dec |
|
Torsade de pointes and sudden death induced by thiopental and isoflurane anesthesia in dogs with cardiac electrical remodeling. | 2002 Jan |
|
Life-threatening hyperkalaemia following therapeutic barbiturate coma. | 2002 Sep |
|
Effect of sodium succinate on gas exchange in rats with barbiturate-induced coma. | 2003 Apr |
|
Thiopental inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappaB through suppression of kappaB kinase activity. | 2003 Aug |
|
Central nervous system toxicity following the administration of levobupivacaine for lumbar plexus block: A report of two cases. | 2003 Mar-Apr |
|
Comparative benefit of preemptively applied thiopental for propofol injection pain: the advantage over lidocaine. | 2004 Mar |
|
Intermediates of Krebs cycle correct the depression of the whole body oxygen consumption and lethal cooling in barbiturate poisoning in rat. | 2004 Oct 1 |
|
Effects of different anaesthetic agents on immune cell function in vitro. | 2005 Aug |
|
The effect of pretreatment with thiopental on reducing pain induced by rocuronium injection. | 2005 Dec 31 |
|
Contrasting anesthetic sensitivities of T-type Ca2+ channels of reticular thalamic neurons and recombinant Ca(v)3.3 channels. | 2005 Jan |
|
Is ketamine a safe anesthetic for percutaneous liver biopsy in a liver transplant recipient immunosuppressed with cyclosporine? | 2005 Jan |
|
Inhibitory effect of thiopental on ultra-rapid delayed rectifier K+ current in H9c2 cells. | 2005 Oct |
|
Pre- or postinsult administration of lidocaine or thiopental attenuates cell death in rat hippocampal slice cultures caused by oxygen-glucose deprivation. | 2005 Oct |
|
Thiopental-induced apoptosis in lymphocytes is independent of CD95 activation. | 2005 Sep |
|
Intravenous propofol precipitates the hypotension induced by inadvertent epidural thiopental injection. | 2006 Dec |
|
Synergism of isothermal regimen and sodium succinate in experimental therapy of barbiturate coma. | 2006 Jul |
|
Fulminant hyperammonaemia induced by thiopental coma in rats. | 2006 Jul 25 |
|
Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. | 2007 Sep |
|
The effect of a 3 : 1 volume mixture of propofol 1% and thiopental 2.5% in reducing the pain on injection of propofol in children. | 2010 Jun |
|
Pretreatment with dexmedetomidine or thiopental decreases myoclonus after etomidate: a randomized, double-blind controlled trial. | 2010 Mar |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.medicines.org.uk/emc/medicine/14338
Thiopental Sodium 500 mg Injection is administered intravenously normally as a 2.5% w/v (500 mg in 20 ml) solution. On occasions it may be administered as a 5% w/v solution (500 mg in 10 ml).
The intravenous injection preparation should be used after reconstitution of the sterile powder with Water for Injections, usually to produce a 2.5% w/v solution and this should be discarded after seven hours.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18619475
In cultured spinal cord slices from mice, thiopental reduced action potential activity with an EC50 of 16.6 ± 2.4 μM. Recordings of GABAA and glycine receptor-mediated inhibitory currents indicated that the effect was largely mediated by GABAA receptors and that glycine receptors were not relevant targets. Specifically, 20 μM thiopental prolonged the decay time of spontaneous GABAergic inhibitory postsynaptic currents (sIPSCs) more than twofold. Although this prolongation of decay time increased the inhibitory charge per sIPSC the concomitant strong reduction of sIPSC frequency resulted in less inhibitory current entering the neurons via this route. However, 20 μM thiopental also induced a tonic current of 30 ± 10 pA, mediated by GABAA receptors; 50 μM thiopental nearly abolished sIPSC activity but augmented tonic currents to 69 ± 14 pA.
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:31:06 GMT 2025
by
admin
on
Mon Mar 31 18:31:06 GMT 2025
|
Record UNII |
JI8Z5M7NA3
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
953
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
||
|
DEA NO. |
2100
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
||
|
WHO-ATC |
N05CA19
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
||
|
NCI_THESAURUS |
C245
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
||
|
WHO-VATC |
QN05CA19
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
||
|
WHO-ATC |
N01AF03
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
||
|
WHO-VATC |
QN01AF03
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
200-984-3
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
3000715
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
CHEMBL441
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
Thiopental
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
SUB04816MIG
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
DTXSID1023653
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
JI8Z5M7NA3
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
1661002
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
DB00599
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
10493
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | RxNorm | ||
|
C72166
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
76-75-5
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
D013874
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
102166
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
2633
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
7791
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
100000088041
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY | |||
|
2579
Created by
admin on Mon Mar 31 18:31:06 GMT 2025 , Edited by admin on Mon Mar 31 18:31:06 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |